TALOS is a joint research effort of 7 academic and 3 industrial partners in the area of bone diseases and in particular of osteoporosis, that was recently funded by the European Community.
The aim of the project is to perform human, animal and basic studies to elucidate the role of LRP5 signaling and its antagonists on bone formation with final objective the identification and experimentally testing molecular targets for the eventual development of bone forming therapeutics for osteoporosis.
This project is supported through Coordination Theme 1 (Health) of the European Community's FP7,
Grant Agreement number HEALTH-F2-2008-201099
The aim of the project is to perform human, animal and basic studies to elucidate the role of LRP5 signaling and its antagonists on bone formation with final objective the identification and experimentally testing molecular targets for the eventual development of bone forming therapeutics for osteoporosis.
This project is supported through Coordination Theme 1 (Health) of the European Community's FP7,
Grant Agreement number HEALTH-F2-2008-201099
